纤维蛋白溶解

xiān wéi dàn bái rónɡ jiě
  • fibrinolysis
纤维蛋白溶解纤维蛋白溶解
  1. 纤维蛋白溶解药物已被用于临床治疗

    Drugs causing fibrinolysis have been utilized therapeutically .

  2. 结论:妇宝胶囊的止血机制主要通过促进内源性和外源性凝血系统,抑制纤维蛋白溶解系统达到目的。

    Conclusion : The main hemostatic mechanism of Fubao capsule was to stimulate the intrinsic and extrinsic blood coagulation system and to inhibit fibrinolysis system .

  3. 抗纤维蛋白溶解药和钙拮抗剂部分通过影响ET含量而发挥作用。

    Antifibrinolytic therapy and calcium antagonists action on SAH partly depended on affecting content of ET in plasma .

  4. He-Ne激光血管内照射对家兔纤维蛋白溶解功能影响的实验研究

    Influence of Intravascular Low level He Ne Laser Irradiation on Fibrinolytic Function in Rabbits

  5. 犯罪损伤处钙与ST段抬高型心肌梗死并接受纤维蛋白溶解治疗患者的血管造影及临床预后之间的联系

    Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy

  6. 目的:本文研究尖吻蝮蛇毒纤维蛋白溶解酶FⅡa体内的溶栓作用。

    AIM : A fibrinolytic enzyme from Agkistrodon acutus venom , called F ⅱ a , was tested for thrombolytic activity in animals .

  7. 肝素修饰rt-PA的纤维蛋白溶解活性提高63%;

    It was found that heparin modification of rt-PA resulted in 63 % increase of fibrinolytic activity .

  8. 结论NV蛋白酶具有纤维蛋白溶解活性,对凝血功能未见有影响。

    Conclusion N-V proteinase possesses the fibrinolysis activity , and the effect on blood coagulation function are not observed .

  9. 目的通过研究膀胱内灌注纤维蛋白溶解抑制剂对卡介苗(BCG)与膀胱壁结合力的影响,探讨提高BCG抗肿瘤疗效的新方法。

    Objective To evaluate the influence upon Bacillus Calmette-Guerin ( BCG ) attachment to bladder wall by intravesical instillation of antifibrinolytic agents and provide a new approach of BCG instillation .

  10. 右旋糖酐和聚乙二醇修饰rt-PA的纤维蛋白溶解活性则分别降低了36%和63%。

    However , the fibrinolytic activity of rt-PA modified with PEG and dextran decreased 63 % and 36 % , respectively .

  11. 结论膀胱内灌注纤维蛋白溶解抑制剂可增强BCG与膀胱壁的结合力,而纤溶促进剂肝素则作用相反,提示前者可提高BCG的抗肿瘤疗效。

    Conclusions Intravesical instillation of antifibrinolytic agent EACA or PAMBA can enhance BCG attachment to bladder wall while fibrinolytic agent heparin inhibit it . This means the former may enhance BCG antineoplastic effect .

  12. 目的探讨重组葡激酶(r-Sak)的溶栓活性及对纤维蛋白溶解系统的影响。

    Objective To investigate the effect of thrombolysis and influence to fibrinolytic system with recombinant staphylokinase ( r-Sak ) .

  13. 为探讨其作用机理,还观察了PGMS对家兔凝血系统和纤维蛋白溶解系统的影响。

    In order to explore the mechanism of antithrombosis of PGMS , we studied the influences on the fibrinolytic and coagulant function of rabbits .

  14. 用肝素、右旋糖酐和聚乙二醇对重组组织型纤溶酶原激活剂(rt-PA)进行化学修饰。不同的化学修饰物对rt-PA体外纤维蛋白溶解活性的影响不同。

    Chemical modification of surface amino groups of recombinant tissue-type plasminogen activator ( rt-PA ) with heparin , polyethylene glycol ( PEG ) and dextran was conducted .

  15. 血友病患者凝血酶激活的纤维蛋白溶解抑制物活性(TAFIa)的检测及其临床意义

    Study on the Levels of Thrombin Activable Fibrinolysis Inhibitor Active ( TAFIa ) in the Patients with Hemophilia

  16. 目的:探讨蛛网膜下隙出血(SAH)后血浆NO、ET含量变化及抗纤维蛋白溶解药氨甲苯酸和钙拮抗剂尼莫地平对其影响。

    Aim : To observe the changes of nitric oxide ( NO ) and endothelin ( ET ) contents in plasma after subarachnoid hemorrhage ( SAH ), and to investigate the effects of antifibrinolytic therapy and calcium antagonists on their changes .

  17. 兔眼玻璃体腔内注射1U纤维蛋白溶解酶7天内只能诱发出部分性PVD87.5%(7/8)。

    The eyes of group B could induce partial PVD 87 . 5 % ( 7 / 8 ) .

  18. 在家兔连续多次给药实验中,测定给药20min时纤维蛋白溶解酶活性显著增加(P<001),凡给药24h后测定,纤维蛋白溶解酶活性均不见明显增强。

    In the experiment on rabbits , in which they were given injections several times continuously , the activity increases markedly 20 minutes after the application ( P < 0.01 ), but there is none 24 hours later .

  19. 0.1U软骨素酶联合0.5U或1.0U纤维蛋白溶解酶眼内注射可以在短期内产生玻璃体后脱离,但在1周内产生的玻璃体后脱离为部分性。

    Posterior vitreous detachment can induced by 0.1 U chondroitinase ABC combined with 0.5U or 1.0U plasmin in 1 week in rabbit eye , but the PVD is partly in 1 week .

  20. 提示TFAP可抑制TXA2的产生,促进血管壁内皮PCI2的生成与释放,并有促纤维蛋白溶解作用,从而抑制血小板聚集,达到防止血栓形成及急性心肌梗塞。

    These data suggest that TFAP may promote the synthesis of PGI_2 , inhibit the production of TXA_2 , stimulate the synthesis of cAMP in platelets , prevent aggregation of platelets , and thereby preventing the formation of thrombi as well as the development of myocardial infarction .

  21. 长龙通注射液对家兔、豚鼠能增加纤维蛋白溶解酶活性,给药后20min、50min时最显著,90min后作用明显减弱或恢复正常。

    This injection is capable of increasing the activity of fibrinolysin in rabbits and cavies , and the best result is seen 20 and 50 minutes after the application , but its effect markedly lessens or gets back to normal 90 minutes after the application .

  22. 蚯蚓纤维蛋白溶解酶的提取分离纯化

    A Study on Extraction and Separation and Purification of Earthworm Fibrinolysin

  23. 妇科恶性肿瘤患者纤维蛋白溶解系统的研究

    Study of the plasma fibrinolysis system in patients with gynecologic malignancies

  24. 纤维蛋白溶解活性动力图形分析及意义

    Analysis and significance of the kinetic figures of fibrinolysis activity

  25. 尖吻蝮蛇毒无出血活性纤维蛋白溶解酶的纯化及其理化性质研究

    Purification and characterization of non-hemorrhagic fibrinolytic enzyme from Agkistrodon acutus

  26. 纤维蛋白溶解作用在中耳粘连中的意义

    The role of fibrinolysis in pathogenesis of middle ears adhesions

  27. 凝血、纤维蛋白溶解活性生成图形的分析

    The Figure Analysis in Activated Resultant for Coagulation and Fibrinolysis

  28. 蜂毒对纤维蛋白溶解活性的影响

    Effect of bee venom on solvent activity of fibrous protein

  29. 目的建立动态检测人纤维蛋白溶解功能的方法。

    Objective To establish a method for kinetic measurement of human fibrinolysis function .

  30. 纤维蛋白溶解酶是溶解血纤维蛋白凝块的药物。

    Fibrinolytic enzymes are agents that dissolve fibrin clots .